Search

Your search keyword '"Arandjelovic, Aleksandra"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Arandjelovic, Aleksandra" Remove constraint Author: "Arandjelovic, Aleksandra"
45 results on '"Arandjelovic, Aleksandra"'

Search Results

1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

2. Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

3. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

4. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

6. The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey

10. Quantitative evaluation of collateral circulation in patients with previous myocardial infarction: relation to myocardial ischemia, angiographic appearance and functional improvement of myocardium

11. Ergonovine-Induced Changes of Coronary Artery Diameter in Patients with Nonsignificant Coronary Artery Stenosis: Relation with Lipid Profile

12. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

17. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

18. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

19. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

22. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

23. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

24. Comparative study of left ventricular wall motion and of reperfusion arrhythmias as signs of successful coronary recanalization

25. An experimental intraoperative quantitative echocardiographic study of myocardial perfusion in dogs

26. Distribution of left coronary artery branches in the African green monkey

28. Prognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patients

29. Should procalcitonin be measured routinely in acute decompensated heart failure?

37. Assessment of the Left Ventricular Chamber Stiffness in Athletes

39. Abstract 3336: Fractional and Coronary Flow Reserve in Prediction of Functional Recovery of Myocardium in Patients with Previous Myocardial Infarction

42. Sudden cardiac death

43. Nephroprotection Prevents Incidence of AKI in Patients Undergoing Elective Percutaneous Coronary Interventions.

44. Perspectives: Rationale and design of the ISACS-TC (International Survey of Acute Coronary Syndromes in Transitional Countries) project

45. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Catalog

Books, media, physical & digital resources